Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Moreno

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Molecular Biology of the Cell|April 28, 2022
Whi5 is diluted and protein synthesis does not dramatically increase in pre-<i>Start</i> G1Kurt M Schmoller, Michael C Lanz, Jacob Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue PlasmacytomasDavid F Moreno, Victoria Clapés, Juan Alfons Soler, et al.
Molecular Therapy. Methods & Clinical Development|July 21, 2022
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cellsAnthony M Battram, Aina Oliver-Caldés, Maria Suárez-Lledó, et al.
Transfusion|May 29, 2019
Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host diseaseJoan Cid, Gloria Carbassé, María Suárez-Lledó, et al.
Frontiers in Immunology|December 9, 2021
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic DiseaseIgnacio Isola, Fara Brasó-Maristany, David F Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Glòria Garrabou, et al.
Annals of Hematology|August 31, 2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced diseaseIgnacio Isola, David F Moreno, Esther Moga, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's MacroglobulinemiaEric Durot, Jithma P Abeykoon, Damien Roos-Weil, et al.
Hemasphere|November 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter RegistryDavid F Moreno, Cristina Jiménez, Fernando Escalante, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Molecular Biology of the Cell|April 28, 2022
Whi5 is diluted and protein synthesis does not dramatically increase in pre-<i>Start</i> G1Kurt M Schmoller, Michael C Lanz, Jacob Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue PlasmacytomasDavid F Moreno, Victoria Clapés, Juan Alfons Soler, et al.
Molecular Therapy. Methods & Clinical Development|July 21, 2022
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cellsAnthony M Battram, Aina Oliver-Caldés, Maria Suárez-Lledó, et al.
Transfusion|May 29, 2019
Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host diseaseJoan Cid, Gloria Carbassé, María Suárez-Lledó, et al.
Frontiers in Immunology|December 9, 2021
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic DiseaseIgnacio Isola, Fara Brasó-Maristany, David F Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Glòria Garrabou, et al.
Annals of Hematology|August 31, 2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced diseaseIgnacio Isola, David F Moreno, Esther Moga, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's MacroglobulinemiaEric Durot, Jithma P Abeykoon, Damien Roos-Weil, et al.
Hemasphere|November 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter RegistryDavid F Moreno, Cristina Jiménez, Fernando Escalante, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Pageof 6